Category Archives: CBD

FARMERS FRIDAY | PRODUCT EARTH, BANK HOLIDAY WEEKEND 23 – 25 AUGUST

The UK’s Premier Hemp, CBD and Cannabis event is starting Friday week! Product Earth is now in it’s fourth year and has gathered unstoppable momentum. This year they have taken over the spectacular National Agricultural Exhibition Centre at Stoneleigh Park. They have partnered with the British Hemp Association and The ASTM will also be speaking to produce an event that

Read more

DEVELOPMENTS IN THE EUROPEAN CANNABIS MARKET | European Monitoring Centre for Drugs and Addiction PAPERS

Content: Introduction (p. 3) l Herbal cannabis (p. 4) l Cannabis resin (p. 6) l Concentrated extracts of cannabis (p. 10) l Edibles (p. 12) l Synthetic cannabinoids (p. 13) l Cannabis-based medicinal products (p. 13) l Conclusions (p. 15) l References (p. 16) l Acknowledgements (p. 19) Key points: This publication reviews how a number of factors impact on the

Read more

MEDICAL MONDAYS | PROJECT CBD’s DOSAGE GUIDE

Optimizing one’s therapeutic use; thanks to Martin Lee @ PROJECT CBD High dose? Low dose? CBD? THC? Optimising one’s therapeutic use of cannabis may take some experimentation. BY MARTIN A. LEE ON MAY 16, 2018 (UPDATED ON APRIL 1, 2019) It can be relatively easy to experience medical benefits from cannabis. A puff or two of tetrahydrocannabinol (THC)-rich flower can do the trick for a lot

Read more

Wednesday Report: FDA Hearing 31st May 2019/ Cannabis-Derived Compounds

“The Food and Drug Administration is announcing a public hearing to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds” PUBLIC HEARING Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public HearingMAY 31, 2019 On This Page Event Information Event Materials Date:May 31, 2019Time:May

Read more

Medical Mondays @ TheHempClub.co.uk

What is the cannabinoid receptor-2 (CB2). Similar to CB1, CB2 is a G protein receptor that serves as a target for endocannabinoids and phytocannabinoids. These CB2 receptors are primarily immunomodulatory and anti-inflammatory. They are expressed on the cell membranes of B cells, T cells and macrophages. When signaled, CB2 receptors are generally inhibitory to immune cell activation. Expression of CB2

Read more

PROJECT CBD TUESDAY | Arthritis: CBD Articles/ Abstracts

Featured articles on Arthritis | Cannabinoid Treatment for Rheumatism: Greg Gerdeman, PhD Arthritis is an inflammation of one or more of your joints. There are many different types, including osteoarthritis (OA) and rheumatoid arthritis (RA). Symptoms may include joint pain, stiffness, or swelling. About one in five people have arthritis. It is more common in women, and people with heart disease or diabetes. Greg Gerdeman, former assistant professor

Read more

Saturday Special | THE EIHA’s POSITION ON HEMP EXTRACTS

EIHA PRESENTATION ON HEMP EXTRACT BY: Lorenza Romanese EIHA Managing Director Daniel Kruse, Board Member Tony Reeves, Advisory Committee 12 March 2019, WG PAFF Committee Who is EIHA and who do they represent: • Originally formed almost 19 years ago; officially founded in 2005. Based in Brussels and Cologne • The only pan-European consortium in the industrial hemp sector •

Read more
« Older Entries